Please note, US employees must be fully vaccinated against COVID-19 prior to the start date unless an accommodation is granted by the Company. The Company uses the definition of “fully vaccinated” assigned by the Centers for Disease Control & Prevention for the purposes of considering satisfaction of this requirement which is a condition of employment.

PROCESS SOLUTIONS


Process Solutions experts collaborate with the world's leading drug developers to help bring life-saving and life-enhancing drug therapies to patients, faster. The expertise, products and services we offer help drug manufacturers develop, make, purify, formulate and assure their drugs, as well as ensure that they meet regulatory safety standards.

We are transforming the path from treatments to cures. Alongside pharmaceutical manufacturers, we advance important molecules across our five franchises: bioprocessing, actives & formulation, end-to-end, gene editing and novel modalities, and testing services.

We provide the industry’s most comprehensive portfolio of high-quality products, services and testing for biopharmaceutical manufacturing. Our products and services are critical for diseases such as breast cancer, lymphoma, diabetes, multiple sclerosis, migraines, Crohn's Disease, pediatric brain cancer, and COVID-19. For decades, we have collaborated with our customers to shape how drug production is done today and will continue to shape the possibilities of tomorrow.

The life science business of Merck KGaA, Darmstadt, Germany operates as MilliporeSigma in the U.S. and Canada.

READY TO
CONNECT WITH US?

Apply below for our Associate Scientist Positions and have a virtual interview with our hiring managers for a day-of hiring decision!
Date: October 20, 2021!


READY TO
CONNECT WITH US?

Apply below for our Associate Scientist Positions and have a virtual interview with our hiring managers for a day-of hiring decision!
Date: October 20, 2021!

Andrew Bulpin Executive VP, Head of Process Solutions

Andrew Bulpin is Head of the Process Solutions Business Unit.  In this role, he oversees R&D, Product Management and Marketing, the Services organization, as well as the Process Solutions Commercial teams.  Bulpin has held several roles since joining Millipore in 2006 as VP for the Upstream Processing business and later assumed leadership of the Services and Solutions business.

Andrew holds a Ph.D. in Organic Chemistry from the Université de Caen, France, a MBA from the University of Strathclyde, Scotland, and a Bachelor degree from the University of Sussex, England.

  • Andrew Bulpin Executive VP, Head of Process Solutions

    Andrew Bulpin is Head of the Process Solutions Business Unit.  In this role, he oversees R&D, Product Management and Marketing, the Services organization, as well as the Process Solutions Commercial teams.  Bulpin has held several roles since joining Millipore in 2006 as VP for the Upstream Processing business and later assumed leadership of the Services and Solutions business.

    Andrew holds a Ph.D. in Organic Chemistry from the Université de Caen, France, a MBA from the University of Strathclyde, Scotland, and a Bachelor degree from the University of Sussex, England.

  • Our Portfolio

    Process Solutions portfolio products and services are sold under three major brands: Millipore®, SAFC® or BioReliance®.

     

     

  • What we do

    Process Solutions helps our customers develop, make, purify, formulate and assure the quality of life-enhancing and life-saving drugs across our five franchises: bioprocessing, actives & formulations, end-to-end, gene editing & novel modalities, and testing services

     

     

     

BE CURIOUS AND STAY CONNECTED

Enter your email and tell us a bit about yourself, and we will keep you updated about latest company news and information about career opportunities that match your interests.

Already signed-up?